Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

NCT06075264 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvar Diseases
HPV Infection
Vulvar HSIL
Pre-Cancerous Dysplasia
HPV Disease
VIN, Usual Type
VIN 2 of Usual Type
VIN 3 of Usual Type
Vin II
Vin III
VIN Grade 2
VIN Grade 3
High Grade Intraepithelial Neoplasia

Interventions

DRUG: Artesunate ointment
DRUG: Placebo ointment

Sponsor

Frantz Viral Therapeutics, LLC

Collaborators

[object Object]